SIRTURO
NDC 59676-702, Bedaquiline Fumarate, tablet, from Janssen Products, LP.
- Product NDC
- 59676-702
- Status
- Listed
- Labeler
- Janssen Products, LP
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204384
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59676-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BEDAQUILINE FUMARATE20 mg/1
Pharmacologic classes
Diarylquinoline Antimycobacterial [EPC]; Diarylquinolines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59676-702-60 | 59676070260 | 60 TABLET in 1 BOTTLE (59676-702-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1534c9ae-4948-4cf4-9f66-222a99db6d0e
Use it
Look up 59676-702 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59676-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59676-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.